Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression
#881630
ClinicalTrials.gov
Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
#889249
ClinicalTrials.gov
Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma
#899843
ClinicalTrials.gov
Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
#916033
ClinicalTrials.gov
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
#982704
ClinicalTrials.gov
Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
#839149
ClinicalTrials.gov
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
#857925
ClinicalTrials.gov
Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
#888428
ClinicalTrials.gov
Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea
#980885
ClinicalTrials.gov
Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
#992021
ClinicalTrials.gov
MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb
#865696
ClinicalTrials.gov
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
#889987
ClinicalTrials.gov
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma
#893186
ClinicalTrials.gov
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
#876910
ClinicalTrials.gov
RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma
#903447
ClinicalTrials.gov
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
#966356
ClinicalTrials.gov
Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape
#202763
IRIS
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial
#834434
ClinicalTrials.gov
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
#863093
ClinicalTrials.gov
MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
#882645
ClinicalTrials.gov
Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma
#18540
ClinicalTrials.gov
A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
#181753
ClinicalTrials.gov
A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) Patients
#325177
ClinicalTrials.gov
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
#356473
ClinicalTrials.gov
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
#628589
ClinicalTrials.gov
NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"
#829868
ClinicalTrials.gov
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
#833352
ClinicalTrials.gov
CP-751,871 Treatment For Patients With Multiple Myeloma
#837053
ClinicalTrials.gov
Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma
#840806
ClinicalTrials.gov
Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
#847489
ClinicalTrials.gov
Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma
#860562
ClinicalTrials.gov
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
#868725
ClinicalTrials.gov
Study of bb2121 in Multiple Myeloma
#891392
ClinicalTrials.gov
Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
#899336
ClinicalTrials.gov
CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma
#907082
ClinicalTrials.gov
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
#914839
ClinicalTrials.gov
Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
#911357
ClinicalTrials.gov
Haploidentical Bone Marrow Stem Cell Transplantation in Patients With Multiple Myeloma
#873974
ClinicalTrials.gov
Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma
#845487
ClinicalTrials.gov
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
#866526
ClinicalTrials.gov
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
#899127
ClinicalTrials.gov
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
#864446
ClinicalTrials.gov
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
#853499
ClinicalTrials.gov
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma
#307447
ClinicalTrials.gov
Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.
#307452
ClinicalTrials.gov
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
#321578
ClinicalTrials.gov
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
#429654
ClinicalTrials.gov
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
#432887
ClinicalTrials.gov
Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma
#804022
ClinicalTrials.gov
Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma
#812747
ClinicalTrials.gov
← Previous
Page 4 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.